Although there are no direct studies on the mutational landscape and molecular profiling in endocrine-related tumors concerning HHLA2, the observed association between HHLA2 and specific mutations in other cancer types suggests that variants in regulatory or signaling genes in endocrine tumors might similarly affect HHLA2 expression. Here, HHLA2 is linked to malignant endocrine neoplasm.